Orchid Chemicals oral formulations plant gets USFDA approval

NEW DELHI: Drug firm Orchid Chemicals & Pharmaceuticals today said US health regulator has inspected and accepted its oral formulations facility near Chennai.

The company's oral formulations facility at Irungattukottai near Chennai was "successfully inspected and accepted by the United States Food and Drug Administration (USFDA) without any observations," Orchid Chemicals & Pharmaceuticals said in a filing to BSE.

The facility manufactures various types of dosage forms such as oral tablets and capsules in diverse dosage strengths.

Cheered by the approval from the USFDA, shares of Orchid Chemicals & Pharmaceuticals today closed at Rs 52.65 per scrip, up 9.92 per cent from its previous close.